cetapred opth.oint. eye ointment
alcon couvreur - prednisolone, sulfacetamide - eye ointment - 10, 0.25 %
cetapred eye oint.
alcon-scientific office - eye ointment
isoptocetapred eye drops
alcon couvreur - prednisolone, sulfacetamide - eye drops - 10, 0.25, 0.5 %
isopto cetapred
electramed ireland limited - prednisolone acetate sulfacetamide sodium -
isopto cetapred 2,50 mg/ml - 100 mg/ml eye drops susp. dropper cont.
novartis pharma sa-nv - prednisolone acetate 2,5 mg/ml; sulfacetamide sodium 100 mg/ml - eye drops, suspension - prednisolone and antiinfectives
catapres-tts-1- clonidine transdermal system patch catapres-tts-2- clonidine transdermal system patch catapres-tts-3- clonidin
technomed inc. - clonidine (unii: mn3l5rmn02) (clonidine - unii:mn3l5rmn02) - catapres‑tts® is indicated in the treatment of hypertension. it may be employed alone or concomitantly with other antihypertensive agents. catapres‑tts® should not be used in patients with known hypersensitivity to clonidine or to any other component of the transdermal system.
catapres- clonidine patch, extended release
rebel distributors corp - clonidine (unii: mn3l5rmn02) (clonidine - unii:mn3l5rmn02) - clonidine 0.1 mg in 24 h - catapres-tts® (clonidine) transdermal therapeutic system is indicated in the treatment of hypertension. it may be employed alone or concomitantly with other antihypertensive agents. catapres-tts transdermal therapeutic system should not be used in patients with known hypersensitivity to clonidine or to any other component of the therapeutic system.
catapres-tts
carsl consulting - clonidine 2.5mg - transdermal patch - 2.5 mg - active: clonidine 2.5mg excipient: calcium stearate - catapres-tts is indicated for the treatment of mild to moderate hypertension. it can be used as monotherapy or concomitantly with other antihypertensive agents if required to enhance hypotensive effect.
catapres-tts
carsl consulting - clonidine 5mg - transdermal patch - 5 mg - active: clonidine 5mg excipient: calcium stearate - catapres-tts is indicated for the treatment of mild to moderate hypertension. it can be used as monotherapy or concomitantly with other antihypertensive agents if required to enhance hypotensive effect.